September 17 - 20, 2019
DoubleTree by Hilton Montreal
Montreal, Quebec, Canada
Sept. 17-20, 2019DoubleTree by Hilton MontrealMontreal, Quebec, Canada
Conference CochairsCrystal Mackall, Stanford University School of Medicine, Stanford, CaliforniaDavid Malkin, The Hospital for Sick Children, Toronto, ON, CanadaStefan Pfister, Hopp Children´s Cancer Center at the NCT Heidelberg (KiTZ) and German Cancer Research Center, Heidelberg, GermanyKimberly Stegmaier, Dana-Farber Cancer Institute, Boston, Massachusetts
This Special Conference will address the unique issues and challenges in investigating the biologic basis of childhood cancers and translating recent findings into new treatment approaches. Presentations will feature the most up-to-date findings on cancer predisposition and surveillance, targeted therapeutics, and immunotherapy. Additionally, the conference will cover advances in our understanding of survivorship, tumor heterogeneity, and oncogenesis in pediatric cancer. In addition to proffered talks from the most highly-rated abstracts during the plenary sessions, two special sessions will highlight the top research that will be presented as posters. A total of thirty abstracts will be selected and presenters will have one minute to present one slide to highlight their most exciting findings which can then be discussed in greater depth during the poster sessions themselves. This conference will bring together basic, clinical, and translational researchers in the field of pediatric cancer with expertise ranging from the most recent advances in the basic mechanisms of childhood cancers to the application of these findings in the clinical setting.
Continuing Medical Education Activity
AMA PRA Category 1 CreditsTM available